Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium-Reference-Cited by-同舟云学术

Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

Published:2023-10 Issue: Volume: Page:
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Takemura Kosuke^ORCID,Ernst Matthew S.,Navani Vishal,Wells J. Connor,Bakouny Ziad,Donskov Frede,Basappa Naveen S.,Wood Lori A.,Meza Luis,Pal Sumanta K.,Szabados Bernadett,Powles Thomas,Beuselinck Benoit,McKay Rana R.,Lee Jae-Lyun,Ernst D. Scott,Kapoor Anil,Yuasa Takeshi,Choueiri Toni K.,Heng Daniel Y.C.

Publisher

Elsevier BV

Subject

Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference30 articles.

1. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial;Mickisch;Lancet,2001

2. Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis;Flanigan;J Urol,2004

3. The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapy;Choueiri;J Urol,2011

4. Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium;Heng;Eur Urol,2014

5. Survival analyses of patients with metastatic renal cancer treated with targeted therapy with or without cytoreductive nephrectomy: a National Cancer Data Base study;Hanna;J Clin Oncol,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis Database;Current Oncology;2024-08-18

2. Pathological Response and Outcomes in Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Immunotherapy-Based Therapies and Undergoing Deferred Cytoreductive Nephrectomy (CN);Clinical Genitourinary Cancer;2024-07

3. Cytoreductive nephrectomy in metastatic renal cell carcinoma;Cochrane Database of Systematic Reviews;2024-06-07

4. Multidisciplinary systemic and local therapies for metastatic renal cell carcinoma: a narrative review;Expert Review of Anticancer Therapy;2024-06-03

5. Complete response of metastatic RCC with caval vein thrombus following treatment with pembrolizumab and axitinib: is it possible to extend the indications for systemic therapy?;Minerva Urology and Nephrology;2024-06